ArticleJournal of orthopaedics and sports medicine2025
Achilles Tendon Flaps in Lower Extremity Reconstructive Surgery: Versatility, Utility, and Patient-Centered Outcomes.
Article in Journal of orthopaedics and sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Achilles tendon defects represent a challenging reconstructive problem in both athletic and comorbid populations. The objective of this review was to evaluate the versatility, clinical utility, and patient-centered outcomes of Achilles tendon-based flaps and reconstructions across trauma, chronic rupture, sports medicine, diabetic foot, and salvage contexts. We performed a PubMed search (between 2015-2025), identified 223 studies that were limited to human subjects and English-language publications. Following application of inclusion and exclusion criteria, 71 full-text articles were assessed, of which 48 met criteria for qualitative synthesis. Eligible designs included randomized controlled trials, prospective and retrospective cohorts, systematic reviews, and case series with ≥10 patients. Data were extracted on study design, population, intervention, follow-up, and outcomes. Narrative synthesis was performed across predefined themes: preoperative assessment, intraoperative technique, postoperative management, functional outcomes, and limb salvage. Achilles tendon-based reconstructions demonstrated consistent adaptability across diverse clinical settings. In athletic and trauma cohorts, minimally invasive hamstring autografts, FHL transfers, and V-Y plasties produced significant improvements in functional scores and return-to-sport rates approaching 70-80%, with rerupture rates <5% in most series. In diabetic and salvage populations, regional flaps such as sural and peroneus brevis achieved durable wound coverage, while free anterolateral thigh flaps enabled composite tendon-skin reconstruction with limb salvage rates of 80-90%. Complications varied by context: venous congestion was most common in sural flaps, while infection rates exceeded 20% in uncontrolled diabetics. Across populations, success depended heavily on patient selection, vascular assessment, and compliance with staged rehabilitation. Achilles tendon flaps and grafts represent a versatile reconstructive strategy capable of restoring elite-level function in athletes while preserving limbs in high-risk diabetic and ischemic patients. Current evidence underscores that outcomes depend less on the specific technique than on appropriate patient selection and perioperative optimization. Future research should prioritize multicenter prospective studies, integration of quality-of-life outcomes, and cost-effectiveness analyses to refine the role of these techniques in lower extremity reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.